Explore more publications!

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on November 3, 2025

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
FibroGen to Report Third Quarter 2025 Financial Results
Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook
Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program With Kyowa Kirin
Biodesix Announces Third Quarter 2025 Results and Highlights
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
Syndax Reports Third Quarter 2025 Financial Results and Provides Business Update
Xenon Reports Third Quarter 2025 Financial Results & Business Update
3-Year Renal Data in Adults with Hypoparathyroidism Treated with TransCon® PTH (Palopegteriparatide) to Be Shared at Kidney Week 2025
Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting
Hyperion DeFi Schedules Third Quarter 2025 Earnings Call for November 13, 2025
A Rockstar Puppet and a Life-Saving Message: NMDP Launches New Awareness Campaign to Help More Patients Receive Cell Therapy
The Heart-Body Connection: How Other Organ Systems Affect Heart Health
UPDATE -- ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
Global High-Purity Solvents Market Surges Amid Demand for Precision and Sustainability
HealthPRO Canada Launches National Council to Accelerate and Scale Health Innovation
Organogenesis Applauds CMS’s Significant Step In Payment Reform
Gene and Cell Therapies Emerge as Front-Runners in Neurology Innovation, with High Expectations in ALS, Parkinson’s, and Neuroimmune Disorders

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions